BioSpace News Archive

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today the commencement of a proposed public offering of $75.0 million of shares of its common stock.

New York think tank, Altru Institute has organized the Altru Global Virus Project to aggregate and curate the best information globally and to foster collaboration among scientists, physicians and entrepreneurs developing cures and treatments worldwide

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that on Tuesday, May 5, 2020, after market close, the Company will release first quarter 2020 results.

According to a new market report published by Persistence Market Research, titled “Australia and New Zealand Market Study on Surgical and Respirator Masks: Australia to Witness Highest Growth by 2021”, the surgical and respiratory mask market in Australia and New Zealand is expected to reach US$137.8 Mn by the end of 2015 and is anticipated to expand at a CAGR of 3.3% from 2015 to 2021, to reach US$167.7 Mn by 2021.

Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced the appointment of Carrie Brownstein, M.D., to the role of Chief Medical Officer

Sutro Biopharma, Inc. (NASDAQ: STRO), today announced that the company has been invited to present updated clinical data from its STRO-002 antibody-drug conjugate (ADC) at the upcoming AACR Virtual Annual Meeting 2020.

Phase 1 Study Combining Tumor Infiltrating Lymphocytes (TIL) and Nivolumab in Non-Small Cell Lung Cancer Funded in Part by Iovance and Stand Up To Cancer

Increasing use of MRI systems for the early detection of diseases has surged the growth of the medical devices industry. With continuous technology advancements, rising preference for non-invasive diagnosis, and increasing incidence of neurological disorders, the global MRI systems market will witness 2X growth by market value over the forecast period of 2019 to 2029.

Stromal vascular fraction is gaining significant importance in various fields, including internal medicine, orthopaedics, plastic and general surgery, and wound healing. Ease of harvest, abundant availability, and stable phenotype are some factors increasing the demand for stromal vascular fraction.

It is unconscionable to force Dr. Theresa Greene or any emergency physician to choose between their family and their oath to their patients.